Skip to main content
logo
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
784.11
-9.15 (-1.15%)
At close: Sep 11, 2026, 4:00 PM EDT
781.49
-2.62 (-0.33%)
After-hours: Sep 11, 2026, 4:40 PM EDT

Regeneron Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
15,53514,34314,20213,11712,17316,072
Revenue Growth
9.29%0.99%8.27%7.76%-24.26%89.14%
Gross Profit
6,9066,3927,1006,8627,02010,774
Operating Income
4,1743,7024,1454,2334,9948,995
Net Income
4,3294,5054,4133,9544,3388,075
Earnings Per Share
40.4341.4838.3434.7738.2271.97
EPS Growth
1.92%8.19%10.27%-9.03%-46.89%135.81%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Product Sales
6,4396,3097,6297,0786,89412,117
Total Collaboration
8,2947,3316,0585,5034,9143,673
Other Product
801.3702.6515536.1365.1281.2
Revenue (Total)
15,53514,34314,20213,11712,17316,072

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17,82318,86617,91316,24114,33412,533
Total Debt
2,7072,9732,9392,7912,7702,700
Net Cash (Debt)
15,11615,89314,97413,45111,5659,833
Net Cash Growth
1.98%6.14%11.32%16.31%17.61%144.18%
Net Cash Per Share
141.21146.35130.09118.30101.8987.64

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4,6814,9794,4214,5945,0157,081
Capital Expenditures
-920.9-898.4-755.9-718.6-590.1-551.9
Free Cash Flow
3,7604,0813,6653,8754,4256,529
Free Cash Flow Growth
-2.42%11.35%-5.44%-12.42%-32.23%225.90%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
44.46%44.57%49.99%52.32%57.67%67.04%
Operating Margin
26.87%25.81%29.19%32.27%41.03%55.97%
Pretax Margin
33.25%36.47%33.66%32.01%39.91%58.03%
Profit Margin
27.87%31.41%31.07%30.14%35.64%50.24%
FCF Margin
24.21%28.45%25.80%29.54%36.35%40.63%

Dividends
Chart
Fiscal YearCurrentFY 2025
Period EndingSep '26 Dec '25
Dividend Per Share
3.7603.520
Dividend Per Share Growth
0%-
Dividend Yield
0.48%0.46%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
19.6217.5817.3723.6317.768.18
Forward PE
13.0817.1115.1919.3617.2911.00
P/FCF Ratio
20.7719.4120.9124.1017.4210.11
PS Ratio
5.035.525.407.126.334.11